Navigation Links
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
Date:6/18/2008

NEW YORK, June 18 /PRNewswire/ -- Danube Pharmaceuticals, Inc., a privately held biopharmaceutical company specializing in the commercial research and development of innovative drugs for ophthalmology, is pleased to announce the appointment of Dr. Barrett Katz, MD, MBA as its Chief Executive Officer.

"I am honored and delighted to join Danube Pharmaceuticals at this inflection point in its history as it advances its lead programs through clinical trials and brings novel bench research to the clinics and bedside," said Barrett Katz, MD, MBA, Chief Executive Officer of Danube.

"We are delighted to welcome Dr. Katz to our team," said David R. Guyer, MD, Chairman of Danube. "His leadership, energy and experience will transform our senior management team and complement the clinical and managerial talents we have. His outstanding reputation in the international ophthalmology community coupled with his expertise in the field of drug development, drug approval and product launch will be invaluable for bringing Danube's product candidates from clinical trials to market effectively and efficiently."

Dr. Katz is a renowned ophthalmologist with over 25 years of experience in clinical trials and medical strategy, drug development and regulatory issues. Prior to joining Danube, Dr. Katz served as Executive Vice President and Chief Medical Officer of Fovea Pharmaceuticals SA, in Paris. Before that he was Vice President for Medical Affairs and Medical Strategy at Eyetech Pharmaceuticals, and had been integral to the team that developed Macugen(TM) and brought it to market.

Dr. Katz also served as Professor of Ophthalmology, Neurology and Neurosurgery, and as the Chairman of the Department of Ophthalmology at The George Washington University School of Medicine in Washington, D.C. While there, he formulated and sponsored a joint fellowship in Ophthalmology drug development, clinical trials, and regulatory affairs with the U.S. Food and Drug Administ
'/>"/>

SOURCE Danube Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barretts Esophagus
2. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
3. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
4. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
5. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
6. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
7. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
8. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
9. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 UFP Technologies, a producer ... has recently introduced a custom insulated shipping container ... The new insulated shipper solves the issue of ... UFP Technologies’ BioShell is a universal storage container ... handling and shipping. The insulated shipper keeps frozen ...
(Date:9/29/2014)... September 30, 2014 Each year ... injuries require medical attention. In the military, burn ... complications to battlefield medical care. More than 800 ... Afghanistan. Burn wounds heal slowly, remain inflamed and ... excessive, physically debilitating and functionally damaging. While developments ...
(Date:9/29/2014)... -- Research and Markets  has announced the addition ... Services, End-User , Application - Global Forecast to 2019" ... global oligonucleotide synthesis market is expected to reach $1,712.1 ... at a CAGR of 9.8% from 2014 to 2019. ... basis of products and services, applications, end users, and ...
(Date:9/29/2014)... Research and Markets  has announced the addition of ... Chromatograph Market by Type , Technology, Spectroscopy, Gas chromatography, ... to 2013 - 2020" report to their offering. ... analytical instrument that provides chemical composition data on process ... which companies carry out their production and improve the ...
Breaking Biology Technology:UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 3Faster Healing with Fewer Scars 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 2Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 4
... at 1:30 p.m. Eastern Time Today, GAITHERSBURG, Md., ... reported financial results and corporate progress for,the full year ... months, we have further demonstrated that Iomai,s,vaccine and immunostimulant ... Erck, president and chief executive officer,of Iomai. "This lays ...
... SOUTH SAN FRANCISCO, Calif., March 6 VaxGen,Inc. (Pink ... financial results and more recent cash balance, with a ... information,ahead of voting on the company,s proposed merger with ... 28, 2008 as the date for the,Special Meeting of ...
... Trellis-8 Catheter From Bacchus Vascular, Reducing Patient ... ... March 6 Bacchus Vascular Inc., a,leading provider of innovative ... for the,minimally invasive treatment of deep vein thrombosis (DVT) and ...
Cached Biology Technology:Iomai Announces Year-End 2007 Financial Results and Business Progress 2Iomai Announces Year-End 2007 Financial Results and Business Progress 3Iomai Announces Year-End 2007 Financial Results and Business Progress 4Iomai Announces Year-End 2007 Financial Results and Business Progress 5Iomai Announces Year-End 2007 Financial Results and Business Progress 6VaxGen Reports Financial Update 2VaxGen Reports Financial Update 3VaxGen Reports Financial Update 4VaxGen Reports Financial Update 5VaxGen Reports Financial Update 6VaxGen Reports Financial Update 7Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis 2
(Date:9/29/2014)... In popular culture, mathematics is often deemed inaccessible or ... ever more important role in our daily lives and ... new ideas often behind the scenes. , UC ... of Mathematics and an assistant professor of mechanical engineering, ... Some of his recent research published in the ...
(Date:9/29/2014)... real-time feedback system together with a human energy delegate ... of 37% in energy consumption when compared to normal ... to a reduction of 713.71 kg of CO 2 ... eight halls, exposed only to the real-time feedback and ... reduction in energy consumption. , Student,s energy-use behaviour is ...
(Date:9/29/2014)... spheres of fluid, not normally considered capable of doing ... droplets of alcohol move through water. In the future, ... to move on your own to be self-moving ... But also non-living entities can be self-moving, report researchers ... Technology in Prague, Czech Republic. , The researchers have ...
Breaking Biology News(10 mins):At the interface of math and science 2At the interface of math and science 3At the interface of math and science 4Scientists make droplets move on their own 2
... levels of allergic asthma and eczema in North American children ... as being "too clean." "We see auto-immune diseases like ... we don,t see the same effect in children in the ... the Michael Smith Laboratories at the University of British Columbia. ...
... shuttle Discovery will make its swan song flight Nov. ... payload devices, including one to help scientists better understand ... low gravity of space as a way to help ... will be carried aboard Discovery in sets of specially ...
... cabinet, eluding capture or worse, making the insects a model ... disaster in search of survivors. But learning how they ... run and turn has been a difficult and time-consuming task. ... a custom computer program, researchers at Case Western Reserve University ...
Cached Biology News:Is our too clean culture making our kids sick? 2Swan song of space shuttle Discovery to carry 2 payloads built by CU-Boulder 2Swan song of space shuttle Discovery to carry 2 payloads built by CU-Boulder 3New software eases analysis of insect in motion 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
... Designed to histochemically detect ... distinct pH in cultured ... The specific marker is ... cells (not found in ...
TAR DNA binding protein...
Biology Products: